Blanket Purchase Agreement V797P5575X-V797D9130

This indefinite delivery contract, awarded by the Defense Logistics Agency (DLA), provides a national supply source for Atenolol 25MG, 50MG, and 100MG tablets in bottle counts of 90 and 1000 to Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers. The single-award, firm-fixed price contract has a one-year base period with four one-year option periods, allowing the government to place delivery orders against established pricing schedules....

The National Acquisition Center awarded a single-award indefinite-delivery contract to Avkare LLC on July 31, 2022, for acetazolamide tablets with a ceiling of $2,075,624.60 and an ultimate completion date of July 30, 2027. The contract carries no set-aside designation. The ordering period runs from July 31, 2022, to July 30, 2023, with four one-year options. The source indicates exercise of the fourth option year with no price changes. Avkare is a pharmaceutical and medical supply distributor...

The National Acquisition Center awarded a single-award indefinite-delivery contract to Golden State Medical Supply, Inc. for metolazone tablets on August 24, 2021, with a ceiling value of $3,413,993.75. The contract carries no set-aside designation. The period of performance runs from August 24, 2021 through August 23, 2022, with four one-year options extending the ultimate completion date to August 23, 2026. Golden State Medical Supply, Inc. is a pharmaceutical manufacturer and distributor...

The Department of Veterans Affairs National Acquisition Center awarded a single-award IDIQ to Golden State Medical Supply, Inc. for Fludrocortisone Acetate 0.1MG tablets with a contract ceiling of $3,083,129.35, effective October 26, 2025. The contract covers one base year with four one-year option periods, running through October 25, 2026 on the base period. No set-aside category applies. The procurement was issued in commercial item format under NAICS code 325412 (Pharmaceutical Preparation...

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $58.6 million single-award contract has a completion date of December 10, 2024 and was originally solicited as an unrestricted commercial item acquisition under FAR Part 12. The primary purpose of the contract is to establish a national supply source for potassium chloride extended release (ER) tablets in 10 MEQ and 20 MEQ...

Exelan Pharmaceuticals Inc., headquartered in Boca Raton, Florida, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency on February 1, 2023, with a contract ceiling value of $28.2 million and an ultimate completion date of January 31, 2028. This firm-fixed-price, requirements-type contract was established without a set-aside designation, allowing full and open competition. The contract originated from a Defense Logistics Agency pre-solicitation announcement...

The Defense Logistics Agency Troop Support Medical awarded a single-award indefinite-delivery contract to Avkare LLC on May 13, 2025, with a ceiling of $15,978,181.35 and an ultimate completion date of May 12, 2030. No set-aside applies; the contract is fully competed on an unrestricted basis. The contract covers pharmaceutical manufacturing and distribution services under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 4610121118. Place of performance is Pulaski, Tennessee....

Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency (DLA) Troop Support Medical with a ceiling value of $39.51 million and a period of performance extending from October 16, 2025, through October 15, 2030. This unrestricted, fully competitive procurement supports the DLA Medical Supply Chain, a defense-oriented federal agency, and establishes Avkare as a prime vendor for...

The Defense Logistics Agency awarded a single-award, indefinite delivery contract to Avkare, LLC to supply Rasagiline Mesylate tablets. The contract has a one-year base period and four one-year options with a potential value of $27,374,128.35 and a period of performance through May 10, 2026. Under the contract, Avkare, LLC will manufacture and distribute Rasagiline Mesylate 0.5MG and 1MG tablets in bottle counts of 30 to meet the medical requirements of the Defense Logistics Agency, Department...

The federal contract IDV award SPE2D219D0070 was granted to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The IDV is a single-award indefinite delivery contract with a ceiling value of $45,158,494.05 and an ultimate completion date of May 28, 2024. Exelan Pharmaceuticals, a key supplier of generic and branded pharmaceutical products to various federal healthcare agencies, will deliver a diverse range of pharmaceutical items...